ImmuneAGE Bio
PrivateLast Round
Seed
Jul 12, 2024
Total Funding Raised
$2.05M
Company Overview
ImmuneAGE Bio operates in Healthcare & Life Sciences and is based in Lausanne. Its latest recorded funding round was a Seed round in July 2024.
ImmuneAGE Bio is a biotechnology company that provides a drug discovery platform focused on rejuvenating the immune system by targeting hematopoietic stem cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ImmuneAGE Bio Comparables
Compare ImmuneAGE Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mogling Bio Inc. | 85% | |
| HexemBio | 85% | |
| ExCellThera | 78% |
For institutional investors. Book with your work email.
ImmuneAGE Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 12, 2024 | ||||
| Pre Seed | May 10, 2023 |
For institutional investors. Book with your work email.
ImmuneAGE Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 1517 Fund | Seed |
| VitaDAO | Pre Seed, Seed |
| Infinita Fund | Seed |
| Healthspan Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors increased 1288% MoM, reaching 958.
- Mar 4, 2026
Monthly visitors grew 108% MoM, reaching 1.2K.
For institutional investors. Book with your work email.
ImmuneAGE Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ImmuneAGE Bio's valuation, stock price, and market status.
Is ImmuneAGE Bio a public or private company?
ImmuneAGE Bio is a private company.
What is the current stock price of ImmuneAGE Bio?
ImmuneAGE Bio is a private company, so its shares have no public market price. Caplight tracks ImmuneAGE Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ImmuneAGE Bio worth (valuation)?
Valuation information for ImmuneAGE Bio is not publicly available.
Can I buy ImmuneAGE Bio stock?
ImmuneAGE Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ImmuneAGE Bio's last funding round?
ImmuneAGE Bio's most recent funding round was Seed on July 12, 2024.
Who are the main investors in ImmuneAGE Bio?
Key investors in ImmuneAGE Bio include 1517 Fund, VitaDAO, Infinita Fund, Healthspan Capital.
Will ImmuneAGE Bio IPO soon?
No public IPO plans have been announced for ImmuneAGE Bio.
How can I track ImmuneAGE Bio secondary market activity?
Caplight tracks bids, offers, and trades in ImmuneAGE Bio's shares on secondary markets.